CN111354461A - Method for screening information of gout high-risk patients - Google Patents
Method for screening information of gout high-risk patients Download PDFInfo
- Publication number
- CN111354461A CN111354461A CN202010140091.4A CN202010140091A CN111354461A CN 111354461 A CN111354461 A CN 111354461A CN 202010140091 A CN202010140091 A CN 202010140091A CN 111354461 A CN111354461 A CN 111354461A
- Authority
- CN
- China
- Prior art keywords
- gout
- abnormal
- patient
- uric acid
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 86
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000012216 screening Methods 0.000 title claims abstract description 22
- 230000002159 abnormal effect Effects 0.000 claims abstract description 78
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims abstract description 68
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims abstract description 68
- 229940116269 uric acid Drugs 0.000 claims abstract description 68
- 238000007689 inspection Methods 0.000 claims abstract description 12
- 230000002265 prevention Effects 0.000 claims abstract description 10
- 238000003745 diagnosis Methods 0.000 claims abstract description 5
- 230000005856 abnormality Effects 0.000 claims description 5
- 238000012790 confirmation Methods 0.000 claims description 3
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010023203 Joint destruction Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
- G06F16/24—Querying
- G06F16/245—Query processing
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
- G06F16/24—Querying
- G06F16/248—Presentation of query results
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/10—Complex mathematical operations
- G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
Landscapes
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Databases & Information Systems (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Mathematical Optimization (AREA)
- Mathematical Analysis (AREA)
- Biomedical Technology (AREA)
- Mathematical Physics (AREA)
- Pure & Applied Mathematics (AREA)
- Computational Linguistics (AREA)
- Computational Mathematics (AREA)
- Pathology (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Operations Research (AREA)
- Probability & Statistics with Applications (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Algebra (AREA)
- Life Sciences & Earth Sciences (AREA)
- Software Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a method for screening information of gout high-risk patients, wherein a gout informatization system is connected with a hospital information system, and the gout informatization system can access and acquire information of a hospital inspection database; the gout informatization system sets a timing scanning program and scans a hospital inspection database at regular time; a uric acid abnormal standard value is set in the gout informatization system; the gout informatization system sets an abnormal patient database; the gout informatization system starts a timing scanning program. The gout informatization system screens and automatically judges abnormal conditions, a high-risk patient abnormity prevention task is completed automatically, medical care personnel do not need to participate in the whole process, and the medical care working efficiency is improved; the high-risk patients are screened abnormally, and the patients are automatically informed by short messages, so that the early prevention effect is efficiently and automatically completed; patients are treated early in diagnosis and early treatment, diseases such as gout and the like are avoided, and the patients benefit for life; gout high-risk patients can be inquired and statistically analyzed in a gout information system, and the prevention effect of clinical departments is greatly improved.
Description
Technical Field
The invention relates to the technical field of gout informatization management systems, in particular to a method for screening information of gout high-risk patients.
Background
The treatment and prevention of gout patients are all important parts of hospital medical treatment, however, treatment related work is in the later stage, and prevention of good disease causes is the core. For gout, hyperuricemia is the basis for gout development, and the definition of hyperuricemia medically for hyperuricemia is: fasting blood uric acid levels twice on non-same day under normal purine diet: male blood uric acid is more than 420 mu mol/L, female blood uric acid is more than 360 mu mol/L;
the preventive screening is now:
the patient actively goes to see a doctor, and at the time, the gout stage is already reached, and the doctor can only control the disease condition and delay the progress of the disease condition;
due to the characteristics of low awareness rate, strong hiding property and high morbidity of patients with high uric acid, a fourth high disease following hypertension, hyperglycemia and hyperlipidemia has been developed at present;
in addition, gout can be complicated with kidney lesion, serious patients can have joint destruction and renal function damage, and the gout is often accompanied with hyperlipidemia, hypertension, diabetes, arteriosclerosis, coronary heart disease and the like, so that the gout has great harm to human health;
however, gout is mainly prevented in health in the forms of tissue medical examination, community public welfare, health lecture hall and the like at present, coverage population is limited and low in efficiency, and gout high-risk people cannot be screened efficiently in rheumatism immunology departments, endocrinology departments and nephrology departments in relevant departments of hospitals, so that a method for screening information of gout high-risk patients is provided.
Disclosure of Invention
The invention aims to provide a gout high-risk patient information screening method to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: a method for screening information of gout high-risk patients comprises the following steps:
the method comprises the following steps: the gout informatization system is connected with the hospital information system, and can access and acquire information of a hospital inspection database;
step two: the gout informatization system sets a timing scanning program and scans a hospital inspection database at regular time;
step three: a uric acid abnormal standard value is set in the gout informatization system;
step four: the gout informatization system sets an abnormal patient database;
step five: the gout informatization system starts a timing scanning program and automatically screens according to the uric acid abnormal standard value;
step six: automatically storing the screened patients with the abnormal uric acid into an abnormal patient database, wherein the patients with the abnormal uric acid standard value are automatically filtered, and are not displayed in a gout informatization system;
step seven: the gout informatization system scans an abnormal patient database and judges whether a newly screened uric acid abnormal patient is in the abnormal patient database;
step eight: when the uric acid abnormal patient is in the abnormal patient database, the abnormal data are displayed in an overlapping mode;
step nine: the gout informatization system acquires basic information of the patient through a hospital information system when the uric acid abnormal patient is not in an abnormal patient database, automatically starts a short message service to inform the uric acid abnormal patient of abnormal examination information in time, guides the uric acid abnormal patient to have contents such as prevention advice, diagnosis confirmation advice and the like, and automatically displays the patient information in the gout informatization system;
step ten: the gout informatization system carries out abnormal data distribution statistics and patient department distribution statistics on uric acid abnormal patients.
Preferably, the hospital information system is a HIS.
Preferably, the standard value of uric acid abnormality comprises a standard value of uric acid for male patients and a standard value of uric acid for female patients; the standard value of uric acid of male patients is 420 mu mol/L, and the standard value of uric acid of female patients is 360 mu mol/L.
Preferably, the timed scanning procedure is initiated at least once daily.
Preferably, the basic information of the patient includes a name, a mobile phone number and an identification number.
Compared with the prior art, the invention has the beneficial effects that: the gout informatization system is used for screening and automatically judging abnormal conditions, the gout informatization system is used for automatically completing the task of preventing the high-risk patient from being abnormal, medical staff do not need to participate in the whole process, and the medical work efficiency is improved;
the abnormal screening of the high-risk patients is carried out, and the patients are automatically informed by short messages, so that the early prevention effect is efficiently and automatically completed;
patients are treated early in diagnosis and early treatment, diseases such as gout and the like are avoided, and the patients benefit for life;
gout high-risk patients can be inquired and statistically analyzed in a gout information system, and the prevention effect of clinical departments is greatly improved.
Drawings
FIG. 1 is a flowchart illustrating the general steps of a method for screening information of patients at high risk of gout according to the present invention;
FIG. 2 is a flowchart of the steps of example 1 in the method for screening gout high-risk patients according to the present invention;
FIG. 3 is a flowchart of the steps of example 2 in the method for screening gout high-risk patients according to the present invention;
fig. 4 is a flowchart illustrating the steps of embodiment 3 in the method for screening information of gout high-risk patients according to the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
It is to be understood that the directional terms used in the description of the present invention are used for convenience in describing the present invention and for simplicity in description, and are not intended to indicate or imply that the apparatus or components so referred to must have a particular orientation, be constructed and operated in a particular orientation, and are not to be construed as limiting the particular scope of the present invention.
Example 1:
referring to fig. 1 and 2, the present embodiment provides a technical solution: fig. 2 is an information screening process for patients who are not screened for gout high risk, which includes the following steps:
the method comprises the following steps: the gout informatization system is connected with the hospital information system, and can access and acquire information of a hospital inspection database;
step two: the gout informatization system sets a timing scanning program and scans a hospital inspection database at regular time;
step three: a uric acid abnormal standard value is set in the gout informatization system;
step four: the gout informatization system sets an abnormal patient database;
step five: the gout informatization system starts a timing scanning program and automatically screens according to the uric acid abnormal standard value;
step six: the screened patients with the standard value not more than the uric acid abnormal standard value are automatically filtered and are not displayed in the gout informatization system;
specifically, the hospital information system is the HIS.
Specifically, the standard values of uric acid abnormality comprise a standard value of uric acid of a male patient and a standard value of uric acid of a female patient; the standard value of uric acid of male patients is 420 mu mol/L, and the standard value of uric acid of female patients is 360 mu mol/L.
Specifically, the timed scanning procedure is started at least once a day.
Example 2:
referring to fig. 1 and 3, the present embodiment provides a technical solution: wherein, fig. 3 is a process for screening information of gout high-risk patients screened for the first time: the method comprises the following steps:
the method comprises the following steps: the gout informatization system is connected with the hospital information system, and can access and acquire information of a hospital inspection database;
step two: the gout informatization system sets a timing scanning program and scans a hospital inspection database at regular time;
step three: a uric acid abnormal standard value is set in the gout informatization system;
step four: the gout informatization system sets an abnormal patient database;
step five: the gout informatization system starts a timing scanning program and automatically screens according to the uric acid abnormal standard value;
step six: automatically storing the screened uric acid abnormal patients into an abnormal patient database;
step seven: the gout informatization system scans an abnormal patient database and judges whether a newly screened uric acid abnormal patient is in the abnormal patient database;
step eight: the gout informatization system acquires basic information of the patient through a hospital information system when the uric acid abnormal patient is not in an abnormal patient database, automatically starts a short message service to inform the uric acid abnormal patient of abnormal examination information in time, guides the uric acid abnormal patient to have contents such as prevention advice, diagnosis confirmation advice and the like, and automatically displays the patient information in the gout informatization system;
step nine: the gout informatization system carries out abnormal data distribution statistics and patient department distribution statistics on uric acid abnormal patients.
Specifically, the hospital information system is the HIS.
Specifically, the standard values of uric acid abnormality comprise a standard value of uric acid of a male patient and a standard value of uric acid of a female patient; the standard value of uric acid of male patients is 420 mu mol/L, and the standard value of uric acid of female patients is 360 mu mol/L.
Specifically, the timed scanning procedure is started at least once a day.
Specifically, the basic information of the patient includes a name, a mobile phone number and an identification number.
Example 3:
referring to fig. 1 and 4, the present embodiment provides a technical solution: fig. 4 is a process for screening information of patients at high risk of gout, which includes the following steps:
the method comprises the following steps: the gout informatization system is connected with the hospital information system, and can access and acquire information of a hospital inspection database;
step two: the gout informatization system sets a timing scanning program and scans a hospital inspection database at regular time;
step three: a uric acid abnormal standard value is set in the gout informatization system;
step four: the gout informatization system sets an abnormal patient database;
step five: the gout informatization system starts a timing scanning program and automatically screens according to the uric acid abnormal standard value;
step six: automatically storing the screened uric acid abnormal patients into an abnormal patient database;
step seven: the gout informatization system scans an abnormal patient database and judges whether a newly screened uric acid abnormal patient is in the abnormal patient database;
step eight: if the uric acid abnormal patient is in the abnormal patient database, displaying abnormal data in an overlapping way, namely if the patient is confirmed to belong to the uric acid abnormal patient in the previous examination, and overlapping the abnormal data in the second examination;
step nine: the gout informatization system carries out abnormal data distribution statistics and patient department distribution statistics on uric acid abnormal patients.
Specifically, the hospital information system is the HIS.
Specifically, the standard values of uric acid abnormality comprise a standard value of uric acid of a male patient and a standard value of uric acid of a female patient; the standard value of uric acid of male patients is 420 mu mol/L, and the standard value of uric acid of female patients is 360 mu mol/L.
Specifically, the timed scanning procedure is started at least once a day.
In the present invention, words such as "comprise", "comprises", and the like are to be interpreted in an inclusive sense as opposed to an exclusive sense; that is, the meaning is included but not limited to, and variations, equivalent substitutions, improvements and the like can be made without departing from the concept of the present invention, which falls within the scope of protection of the present invention, and contents not described in detail in the present specification are known to those skilled in the art.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (5)
1. A method for screening information of gout high-risk patients is characterized by comprising the following steps: the method comprises the following steps:
the method comprises the following steps: the gout informatization system is connected with the hospital information system, and can access and acquire information of a hospital inspection database;
step two: the gout informatization system sets a timing scanning program and scans a hospital inspection database at regular time;
step three: a uric acid abnormal standard value is set in the gout informatization system;
step four: the gout informatization system sets an abnormal patient database;
step five: the gout informatization system starts a timing scanning program and automatically screens according to the uric acid abnormal standard value;
step six: automatically storing the screened patients with the abnormal uric acid into an abnormal patient database, wherein the patients with the abnormal uric acid standard value are automatically filtered, and are not displayed in a gout informatization system;
step seven: the gout informatization system scans an abnormal patient database and judges whether a newly screened uric acid abnormal patient is in the abnormal patient database;
step eight: when the uric acid abnormal patient is in the abnormal patient database, the abnormal data are displayed in an overlapping mode;
step nine: the gout informatization system acquires basic information of the patient through a hospital information system when the uric acid abnormal patient is not in an abnormal patient database, automatically starts a short message service to inform the uric acid abnormal patient of abnormal examination information in time, guides the uric acid abnormal patient to have contents such as prevention advice, diagnosis confirmation advice and the like, and automatically displays the patient information in the gout informatization system;
step ten: the gout informatization system carries out abnormal data distribution statistics and patient department distribution statistics on uric acid abnormal patients.
2. The method for gout high risk patient information screening according to claim 1, wherein: the hospital information system is HIS.
3. The method for gout high risk patient information screening according to claim 1, wherein: the uric acid abnormality standard values comprise a uric acid standard value for a male patient and a uric acid standard value for a female patient; the standard value of uric acid of male patients is 420 mu mol/L, and the standard value of uric acid of female patients is 360 mu mol/L.
4. The method for gout high risk patient information screening according to claim 1, wherein: the starting frequency of the timing scanning program is at least once a day.
5. The method for gout high risk patient information screening according to claim 1, wherein: the basic information of the patient comprises a name, a mobile phone number and an identification number.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010140091.4A CN111354461A (en) | 2020-03-03 | 2020-03-03 | Method for screening information of gout high-risk patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010140091.4A CN111354461A (en) | 2020-03-03 | 2020-03-03 | Method for screening information of gout high-risk patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111354461A true CN111354461A (en) | 2020-06-30 |
Family
ID=71197322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010140091.4A Pending CN111354461A (en) | 2020-03-03 | 2020-03-03 | Method for screening information of gout high-risk patients |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111354461A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113628743A (en) * | 2021-07-01 | 2021-11-09 | 新绎健康科技有限公司 | Uric acid abnormity screening method and system based on gas discharge imaging technology |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1185305A (en) * | 1996-06-17 | 1998-06-24 | 史密丝克莱恩比彻姆公司 | Method for identifying and diagnosing lifetreatened patient suffering from congestive heart-failture and system |
| WO2019070200A1 (en) * | 2017-10-05 | 2019-04-11 | Integral Technologies (S) Pte. Ltd. | A healthcare information management system |
-
2020
- 2020-03-03 CN CN202010140091.4A patent/CN111354461A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1185305A (en) * | 1996-06-17 | 1998-06-24 | 史密丝克莱恩比彻姆公司 | Method for identifying and diagnosing lifetreatened patient suffering from congestive heart-failture and system |
| WO2019070200A1 (en) * | 2017-10-05 | 2019-04-11 | Integral Technologies (S) Pte. Ltd. | A healthcare information management system |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113628743A (en) * | 2021-07-01 | 2021-11-09 | 新绎健康科技有限公司 | Uric acid abnormity screening method and system based on gas discharge imaging technology |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McGillion et al. | Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) technology versus standard care: randomised controlled trial | |
| Janjua et al. | Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD) | |
| Nordal et al. | A comparative study of teleconsultations versus face-to-face consultations | |
| US6302844B1 (en) | Patient care delivery system | |
| US20070033073A1 (en) | System and user interface for monitoring patient treatment orders | |
| Heinzelmann et al. | Clinical outcomes associated with telemedicine/telehealth | |
| Chan et al. | The role of telenursing in the provision of geriatric outreach services to residential homes in Hong Kong | |
| Terschüren et al. | Implementing telemonitoring in the daily routine of a GP practice in a rural setting in northern Germany | |
| CN111354461A (en) | Method for screening information of gout high-risk patients | |
| Roth et al. | Telemedicine in emergency home care—the ‘Shahal’experience | |
| Gold et al. | Psychiatric screening in the emergency department: its effect on physician behavior | |
| US20170032094A1 (en) | Apparatus, method, and medium for aiding successful outpatient orthopedic surgery | |
| Noedel et al. | Critical pathways as an effective tool to reduce cardiac transplantation hospitalization and charges | |
| Edirippulige | Readiness of nurses for practicing telehealth | |
| O'Grady et al. | Effectiveness of changes in the delivery of diabetes care in a rural community | |
| Marcucci et al. | Effect of Post discharge after surgery Virtual Care with Remote Automated Monitoring technology versus standard care: The PVC-RAM-1 randomised controlled trial | |
| Molao et al. | Postoperative eye care in Botswana: the role of ophthalmic nurses | |
| Atkinson et al. | Integration of a medication management model into outcome-based quality improvement: a pilot program in a rural proprietary home healthcare agency | |
| Stone et al. | Health care quality in prisons: A comprehensive matrix for evaluation | |
| Darkins et al. | Remote patient monitoring in home healthcare: lessons learned from advanced users | |
| Neyman | TREATMENT AND CARE OF HOME ELDERLY CARE AS AN ALTERNATIVE TO INSTITUTIONAL HOSPITALIZATION | |
| Ebbens et al. | SCREENING BY PHARMACY TECHNICIANS COMPARED TO ANAESTHESIOLOGISTS | |
| Sherman et al. | CHANGE IN USE OF REMOTE HEALTH TECHNOLOGIES AMONG OLDER AFRICAN AMERICAN MEN DURING THE COVID-19 PANDEMIC | |
| Avdeyev et al. | OP16 Assessing The Viability Of Medical Equipment Procurement In Hospital | |
| Punke et al. | Barriers and Facilitators to Implementing Medicare’s Chronic Care Management in Rural Primary Care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200630 |
|
| RJ01 | Rejection of invention patent application after publication |